An uncurable disease (hemophilia type B) could be cured
Post number #273965, ID: 07ce5c
|
Scientists at the Salk Institute have combined CRISPR-Cas9 gene editing with stem cell technology to generate a one-time, autologous cell therapy for the genetic blood clotting disorder hemophilia B. In vivo tests showed that gene-edited, stem cell–derived liver cells remained viable and functional in hemophiliac mice for nearly a year, after just a single injection. >source: www.genengnews.com https://tinyurl.com/ybdj62gx
Post number #274035, ID: 1f55bd
|
nice
Post number #274202, ID: 7b112a
|
Well, that's cool.
Post number #274215, ID: 4830dc
|
Finally some fucking good news
Post number #274246, ID: 9c5c28
|
So this uses gene therapy right?
Post number #275240, ID: 07ce5c
|
>>274246 kinda. Depends on what you consider a gene therapy. My understanding - they modified the genes in stem cells, put them back in the mouse to override the existing gene pattern in its liver.
Total number of posts: 6,
last modified on:
Sat Jan 1 00:00:00 1525866495
| Scientists at the Salk Institute have combined CRISPR-Cas9 gene editing with stem cell technology to generate a one-time, autologous cell therapy for the genetic blood clotting disorder hemophilia B. In vivo tests showed that gene-edited, stem cell–derived liver cells remained viable and functional in hemophiliac mice for nearly a year, after just a single injection.
>source: www.genengnews.com https://tinyurl.com/ybdj62gx